Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Papulosquamous

Explore clinical trials studying Skin Diseases, Papulosquamous. Study availability and eligibility vary by location and protocol.

1,740 public trials 205 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Papulosquamous trial results

Active, Not Recruiting

Study to Evaluate the Effectiveness of Risankizumab in Participants With a Recent Diagnosis of Moderate Plaque Psoriasis in a Real-life Setting in Greece

NCT06247319

Conditions
Moderate Plaque Psoriasis, Moderate Psoriasis, Psoriasis, +3 more
Locations
  • Olympion General Clinic /ID# 266258 Pátrai, Achaia, Greece
  • Iatriko Psichikou /ID# 272851 Athens, Attica, Greece
  • 251 Hellenic Air Force General Hospital /ID# 268135 Athens, Attica, Greece
  • University General Hospital Attikon /ID# 263442 Athens, Attica, Greece
View all 22 locations
View Trial Details
Active, Not Recruiting

Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis

NCT06142357

Conditions
Moderate-to-severe Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Novartis Investigative Site Chelyabinsk, Russia
  • Novartis Investigative Site Grozny, Russia
  • Novartis Investigative Site Izhevsk, Russia
  • Novartis Investigative Site Kazan', Russia
View all 16 locations
View Trial Details
Active, Not Recruiting

Tilrdakizumab Almirall

NCT07244744

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • CCIM, Institut für Entzündungsmedizin UKSH Lübeck Lübeck, <Keine Auswahl>, Germany
View Trial Details
Active, Not Recruiting

Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis

NCT04036435

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Total Skin and Beauty Dermatology Center Birmingham, Alabama, United States
  • Local Institution - 0278 Birmingham, Alabama, United States
  • Alliance Dermatology and Mohs Center - Phoenix Phoenix, Arizona, United States
  • Arizona Research Center Phoenix, Arizona, United States
View all 302 locations
View Trial Details
Active, Not Recruiting

Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work Productivity

NCT05132231

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • CARE Site 42 Calgary, Alberta, Canada
  • CARE Site 26 Calgary, Alberta, Canada
  • CARE Site 15 Calgary, Alberta, Canada
  • CARE Site 18 Edmonton, Alberta, Canada
View all 42 locations
View Trial Details
Active, Not Recruiting

An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects

NCT03240809

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Bausch Site 003 San Diego, California, United States
  • Bausch Site 002 Miami, Florida, United States
  • Bausch Site 004 Miami, Florida, United States
  • Bausch Site 005 Henderson, Nevada, United States
View Trial Details

Related conditions